| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |